Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by investclubon Oct 27, 2019 7:05pm

162 Views

Post# 30274806

What happens between IND & 1st patient results?

Do we see the rest of Canadian sites announced and one patient per month added or will patient enrollment speed up? How long after IND approval states side will we see their sites announced also how long after that do we hear something on patient enrollment down there? Will Canada beat the states in basketball again? ... oooppss off topic

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments